| 000 | 01879 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513215651.0 | ||
| 264 | 0 | _c20000919 | |
| 008 | 200009s 0 0 eng d | ||
| 022 | _a0027-8424 | ||
| 024 | 7 |
_a10.1073/pnas.97.17.9753 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMacarthur, H | |
| 245 | 0 | 0 |
_aInactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. _h[electronic resource] |
| 260 |
_bProceedings of the National Academy of Sciences of the United States of America _cAug 2000 |
||
| 300 |
_a9753-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdrenochrome _xblood |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCatecholamines _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEpinephrine _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aHypotension _xblood |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aLipopolysaccharides _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aManganese |
| 650 | 0 | 4 |
_aNorepinephrine _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aOrganometallic Compounds _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aShock, Septic _xblood |
| 650 | 0 | 4 |
_aSuperoxide Dismutase _xmetabolism |
| 650 | 0 | 4 |
_aSuperoxides _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aVasoconstriction _xdrug effects |
| 650 | 0 | 4 |
_aVasoconstrictor Agents _xantagonists & inhibitors |
| 700 | 1 | _aWestfall, T C | |
| 700 | 1 | _aRiley, D P | |
| 700 | 1 | _aMisko, T P | |
| 700 | 1 | _aSalvemini, D | |
| 773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 97 _gno. 17 _gp. 9753-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.97.17.9753 _zAvailable from publisher's website |
| 999 |
_c10893041 _d10893041 |
||